BCCC-CURE/ASRC Half Day Scientific Symposium "Diverse Approaches to Cancer Therapy"
–
March 25, 2022
- Targeted Perturbation of Epigenetic Landscape for Solid Tumor Therapy, Adegboyega K. Oyelere, Ph.D., Georgia Institute of Technology
- Computer-aided molecular design: from virtual screening to de novo generation with models of chemical reactivity, Connor Coley, Ph.D., The Massachusetts Institute of Technology
- HIF-2alpha inhibitors: Role of basic science in starting path to clinical use, Kevin H. Gardner, Ph.D., Advanced Science Research Center – City University of New York
- HIF2 inhibitors Clinical Development and trials, Toni Choueiri, M.D., Dana-Faber Cancer Institute Harvard University
- Student Opportunities:
- BCCC-CURE Garil Research Internships
- Mt. Sinai School of Medicine Lay Health Advocate Training
- Panel Discussion
Please register for this virtual here.